vW ABNORMAL CONTROL PLASMA

Elevate Assay Confidence: Abnormal Control Plasma for Precision Verification of Ristocetin CoFactor Activity Test

vW Abnormal Control Plasma is prepared from a pool of normal infection negative human plasma which has been partially depleted of vW Factor and then lyophilized. If is used to verify the performance and sensitivity of the Ristocetin CoFactor Activity test.

Lyophilized Human Abnormal Control Plasma
Depleted to Have Less than 45% Ristocetin CoFactor Activity
Verify Ristocetin CoFactor Activity Assay Performance and Sensitivity
Includes Lot Specific Assay Value Sheet
Use with Most Light Transmission Aggregometers
Plasmas Traceable to WHO Standard Reference Plasma
Suitable for Veterinary Use

Derived from meticulously selected normal infection-negative human plasma, our vW Abnormal Control Plasma undergoes a precise process of partial vW Factor depletion and subsequent lyophilization. This specialized product serves as a pivotal tool for validating the performance and sensitivity of the Ristocetin Cofactor Activity test.

Crafted from a pool of normal infection-negative human plasma, this Lyophilized Human Abnormal Control Plasma is carefully depleted of vW Factor to ensure targeted performance evaluation. Its primary purpose is to rigorously verify the precision and sensitivity of the Ristocetin Cofactor Activity test.

Explore Product Data Sheet

Included in each package is a lot-specific Assay Value Sheet, providing a detailed breakdown of assay values. This transparency ensures traceability and facilitates a comprehensive understanding of the product's performance.

Our Lyophilized Human Abnormal Control Plasma is compatible with most Light Transmission Aggregometers, offering versatility in assay methodologies. This compatibility enhances the adaptability of the product to different laboratory setups and testing procedures.

Furthermore, the plasma's traceability to the World Health Organization (WHO) Standard Reference Plasma guarantees a high standard of quality. This meticulous traceability ensures that our product adheres to globally recognized benchmarks, instilling confidence in its reliability.

Beyond human diagnostics, this product is suitable for veterinary use, expanding its scope of utility. Its adaptability for veterinary applications further underscores its versatility and relevance in diverse medical settings.

In the context of clinical significance, the Ristocetin Cofactor Assay Activity is a critical parameter for diagnosing and evaluating von Willebrand syndrome. When utilized as a patient specimen, our Abnormal Control Plasma serves as a valuable assurance, enhancing the sensitivity of the test system to deficiencies in the Ristocetin Cofactor Assay Activity Test.

Each package contains 3 vials, each containing 0.5 mL, providing ample resources for thorough testing and validation. Elevate your diagnostic confidence with our vW Abnormal Control Plasma, a pinnacle in precision and reliability.

Delve into the details on this page, specifically the vW Abnormal Control Plasma Product Data Sheet. Also, explore the vW Abnormal Control Plasma Instruction for Use (IFU) and the vW Abnormal Control Plasma Safety Data Sheet (SDS), both provided in six languages. Ensure compliance and a nuanced understanding customized for Europe and the United Kingdom by thoroughly reviewing the vW Abnormal Control Plasma EU and UK Declaration of Conformity for our valued customers and distributors. A thorough examination of this information is necessary for a comprehensive grasp of the product's details and specifications.

Bio/Data Corporation’s Aggregation Reagents: Accessible Safety Data Sheets for Secure Handling

Bio/Data Corporation provides comprehensive Safety Data Sheets (SDS) for each of its carefully formulated aggregation reagents. These essential documents ensure safe handling, storage, and spill management while offering clear instructions on potential hazards. Designed for easy viewing, saving, and printing, the SDS are readily accessible to support a safe work environment and responsible chemical management.

Product Description

von Willebrand Factor Abnormal Control Plasma is lyophilized citrated human plasma which has been selectively depleted of von Willebrand Factor.

Review Instructions For Use

Intended Purpose

vW Abnormal Control Plasma is prepared from a pool of normal infection negative human plasma which has been partially depleted of vW Factor and then lyophilized. It is used to verify the performance and sensitivity of the Ristocetin Cofactor Activity test.

Test Principle

The Ristocetin Cofactor Assay is a property of the protein which is quantitated in plasma for the diagnosis and evaluation of von Willebrand syndrome. When assayed as a patient specimen, Abnormal Control Plasma ensures the sensitivity of the test system to deficiencies in the von Willebrand factor.

READ MORE... Easily Download the vW Abnormal Control Plasma Instructions for Use in Your Selected Language.

Reagents Provided

vW Abnormal Control Plasma, 3 x 0.5mL.

Reagents and Materials Required but Not Provided

Purified Water (Distilled, Deionized, Reagent Grade), pH 5.3 – 7.2 for reconstitution
TRIS Buffered Saline (TBS) or 0.85% physiologic saline for dilutions

NOTE: USING BLOOD BANK SALINE WILL CAUSE ERRONEOUS RESULTS.

Materials and Accessories

Platelet Aggregometer
Centrifuge
Electronic Pipette
Pipette Tips
Aggregometer Test Tubes (Siliconized)
Aggregometer Stir Bars (Plastic Coated)
Plastic Sample Tubes and Caps (For Dilutions)

Reagent Storage

Upon receipt, store vW Abnormal Control Plasma at 2 – 8° C in its original packaging.
Reconstituted vW Abnormal Control Plasma is stable for 8 hours when stored in its’ tightly capped, original container at 2 – 8° C.
Dilutions using vW Abnormal Control Plasma are less stable and must be used within 40 minutes of preparation.

vW Abnormal Control Plasma 103025 Vials Clear.png

Bio/Data Corporation's Commitment to IVDR Compliance
Bio/Data Corporation proudly complies with the stringent EU In Vitro Diagnostic Regulation (IVDR) 2017/746 and other relevant legislation. Through its Declaration of Conformity (DOC), the company ensures that its devices meet essential health, safety, and environmental standards.

Bio/Data Corporation's Commitment to UKCA Compliance
Bio/Data Corporation ensures product excellence by strictly adhering to UKCA regulations. The company's Declaration of Conformity (DOC) affirms its dedication to meeting health, safety, and environmental standards outlined in UKCA directives and any related updates, demonstrating its unwavering commitment to compliance.

View EU Declaration of Conformity